Literature DB >> 3928729

Allergic reactions to streptokinase consistent with anaphylactic or antigen-antibody complex-mediated damage.

K G McGrath, B Zeffren, J Alexander, K Kaplan, R Patterson.   

Abstract

Streptokinase used as a thrombolytic agent may produce immunologic drug reactions. We report a second case of IgE-mediated anaphylaxis and a late reaction to streptokinase. This late reaction was consistent with an IgG-mediated antigen-antibody disease with transient renal involvement, fever, and cutaneous lesions. The second case responded to prednisone therapy.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3928729     DOI： 10.1016/0091-6749(85)90726-2

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


  14 in total

1.  A rapid agglutination assay to detect anti-streptokinase antibodies.

Authors:  J P McRedmond; N T Mulvihill; M Kane; B Burke; B Aloul; T Forde; M Walsh; D J Fitzgerald
Journal:  Ir J Med Sci       Date:  2004 Oct-Dec       Impact factor: 1.568

2.  Purification and characterization of a fibrinolytic subtilisin-like protease of Bacillus subtilis TP-6 from an Indonesian fermented soybean, Tempeh.

Authors:  Seong-Bo Kim; Dong-Woo Lee; Chan-Ick Cheigh; Eun-Ah Choe; Sang-Jae Lee; Young-Ho Hong; Hak-Jong Choi; Yu-Ryang Pyun
Journal:  J Ind Microbiol Biotechnol       Date:  2006-02-10       Impact factor: 3.346

3.  The effects of age and gender on the pharmacokinetics and pharmacodynamics in healthy subjects of the plasminogen activator, lanoteplase.

Authors:  Nimish N Vachharajani; Ralph H Raymond; Wen-Chyi Shyu; Bruce C Stouffer; David W Boulton
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

4.  Serum sickness and acute renal failure after streptokinase therapy for myocardial infarction.

Authors:  K A Davies; P Mathieson; C G Winearls; A J Rees; M J Walport
Journal:  Clin Exp Immunol       Date:  1990-04       Impact factor: 4.330

5.  Isolation and properties of fibrinolytic subtilisin-like serine protease secreted by the Bacillus subtilis strain B-2805.

Authors:  A A Alekseev; P K Koutsenogiy; P N Miroshnikov; M A Shilova
Journal:  Dokl Biochem Biophys       Date:  2014-05-03       Impact factor: 0.788

Review 6.  Does the potential for development of streptokinase antibodies change the risk-benefit ratio in older patients?

Authors:  J Brügemann; P A de Graeff; J van der Meer; K I Lie
Journal:  Drugs Aging       Date:  1995-08       Impact factor: 3.923

7.  Adverse reaction to streptokinase with multiple systemic manifestations.

Authors:  I Montserrat; J Altimiras; M Dominguez; R Lamich; A Ollé; J Fontcuberta
Journal:  Pharm World Sci       Date:  1995-09-22

8.  Acute renal failure following intravenous streptokinase infusion for acute myocardial infarction.

Authors:  Y Birnbaum; B Strasberg; E Rechavia; Y Neuman; B Stahl
Journal:  West J Med       Date:  1993-04

9.  Immunoglobulin response to intravenous streptokinase in acute myocardial infarction.

Authors:  M Lynch; W A Littler; B L Pentecost; R A Stockley
Journal:  Br Heart J       Date:  1991-08

Review 10.  Adverse reactions to thrombolytic agents. Implications for coronary reperfusion following myocardial infarction.

Authors:  J Nazari; R Davison; K Kaplan; D Fintel
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.